這是什麼
Beta-amyloid comes from breakdown of a larger amyloid precursor protein and can collect between neurons as plaques in Alzheimer disease.[1]
為什麼重要
Anti-amyloid antibodies target amyloid biology and have been approved for certain early Alzheimer disease contexts.[2,3]
它會影響哪些判斷
- Confirmed amyloid pathology is part of the treatment population described in FDA donanemab approval information.[2]